Inhalation surfactant therapy in the integrated treatment of severe COVID-19 pneumonia

Inhalation surfactant therapy in the integrated treatment of severe COVID-19 pneumonia

The objective: to evaluate the effectiveness of inhaled surfactant therapy in the integrated treatment of severe COVID-19 pneumonia in a multicenter prospective clinical trial of surfactant-BL.Subjects and methods. 122 patients with severe COVID-19-associated pneumonia treated in two treatment cente...

Full description

Saved in:
Bibliographic Details
Main Authors: A. E. Bautin, S. N. Avdeev, A. A. Seyliev, M. V. Shvechkova, Z. M. Merzhoeva, N. V. Trushenko, A. P. Semenov, K. B. Lapshin, O. A. Rozenberg
Format: Article
Language:Russian
Published: New Terra Publishing House 2020-10-01
Series:Туберкулез и болезни лёгких
Subjects:
covid-19
influenza a/h1n1
viral pneumonia
ards
acute respiratory failure
Online Access:https://www.tibl-journal.com/jour/article/view/1456
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tibl-journal.com/jour/article/view/1456

Similar Items